S-Carboxymethyl-l-cysteine: a multiple dosing study using pharmacokinetic modelling

References

• Aiache J-M, Borel JP, Kantelip J-P. 1982. Comparative bioavailability of S-carboxymethylcysteine from two dosage forms: hard gelatin capsule and syrup. Biopharm Drug Dispos. 3(3):275–281.
   PubMed Web of Science ®Google Scholar
• Bi H-C, Zhong G-P, Huang M, Zhou S, Huang L-H, Zeng G-X, Liao X-X, Chen X, Pang Y. 2005. Bioequivalence evaluation of two tablet formulations of carbocysteine in healthy Chinese men. J App Res. 5:598–604.
   Google Scholar
• Boonyapiwat B. 2005. Carbocysteine sulphoxidation and its effect on mucoactivity [PhD thesis]. London: King’s College London.
   Google Scholar
• Braga PC, Borsa M, De Angelis L, Bossi R, Allegra L, Scaglione F, Scarpazza G. 1982. Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis. Clin Ther. 4:480–488.
   PubMed Web of Science ®Google Scholar
• Bron, J., 1988. Relative bioavailability of carbocysteine from three dosage forms investigated in healthy volunteers. Biopharmaceutics and drug disposition, 9, 97–111.
   PubMed Web of Science ®Google Scholar
• Brandolini L, Allegretti M, Berdini V, Cervellera MN, Mascagni P, Rinaldi M, Melillo G, Ghezzi P, Mengozzi M, Bertini R. 2003. Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs). Eur Cytokine Network. 14 (1):20–26.
   PubMed Web of Science ®Google Scholar
• Brockmöller J, Staffeldt B, Roots I. 1991. Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification. Eur J Clin Pharmacol. 40(4):387–392.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhong D, Han Y, Xie Z. 2003. Determination of carbocysteine in human plasma by liquid chromatography/tandem mass spectrometry employing precolumn derivatization. Rapid Commun Mass Spectrom. 17(3):192–196.
   PubMed Web of Science ®Google Scholar
• De Schutter JA, van der Weken G, van den Bossche W, de Moerloose P. 1988. Determination of S-carboxymethylcysteine in serum by reversed-phase ion-pair liquid chromatography with column switching following pre-column derivatization with o-phthalaldehyde. J Chromatogr Biomed Appl. 428:301–310.
   Google Scholar
• Drevon D, Fursa SR, Malcolm AL. 2017. Intercoder reliability and validity of WebPlotDigitizer in extracting graphed data. Behav Modif. 41(2):323–339.
   PubMed Web of Science ®Google Scholar
• Dubruc C, Hermann PH, Haddouche A, Badarani MM, Thenot JP. 1987. Determination of S-carboxymethyl-L-cysteine in plasma by high performance liquid chromatography with column switching following precolumn derivatization. J Chromatogr Biomed Appl. 417:208–215.
   Google Scholar
• Hanaoka M, Droma Y, Chen Y, Agatsuma T, Kitaguchi Y, Voelkel NF, Kubo K. 2011. Carbocisteine protects against emphysema induced by cigarette smoke extract in rats. Chest. 139(5):1101–1108.
   PubMed Web of Science ®Google Scholar
• Inoue M, Ishibashi Y, Nogawa H, Yasue T. 2012. Carbocisteine promotes phagocytosis of apoptotic cells by alveolar macrophages. Eur J Pharmacol. 677(1-3):173–179.
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Inouye Y, Taniguchi A. 2012. [Expression and role of sugar chains on airway mucus during the exacerbation of airway inflammation]. Yakugaku Zasshi. 132(6):699–704.
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Takayama G, Inouye Y, Taniguchi A. 2010. Carbocisteine normalizes the viscous property of mucus through regulation of fucosylated and sialylated sugar chain on airway mucins. Eur J Pharmacol. 641(2–3):226–228.
   PubMed Web of Science ®Google Scholar
• Ishii Y, Kimura T, Morishima Y, Mochizuki M, Nomura A, Sakamoto T, Uchida Y, Sekizawa K. 2002. S-carboxymethylcysteine inhibits neutrophil activation mediated by N-formyl-methionyl-leucyl-phenylalanine. Eur J Pharmacol. 449(1–2):183–189.
   PubMed Web of Science ®Google Scholar
• Joullie M, Laurre M, Maillard G, Muller P. 1961. Medicament soufre, utilisable en particulier en oto-rhino-laryngologie et an pneumologie. 1961 Feb 27. French Patent (Fr. Demande) FR M226 to Recherches et Propagande Scientifiques.
   Google Scholar
• Jovanovic D, Cusic S, Segrt Z, Dorevic D, Vehabovic M, Potogija N. 2005. A comparative bioavailability study of a generic capsule formulation containing carbocysteine. Pharmazie. 61:446–449.
   Web of Science ®Google Scholar
• Livingstone CR, Andrews MA, Jenkins SM, Marriott C. 1990. Model systems for the evaluation of mucolytic drugs: acetylcysteine and S-carboxymethylcysteine. J Pharm Pharmacol. 42 (2):73–78.
   PubMed Web of Science ®Google Scholar
• Maynard WR, Bruce RB, Fox GG. 1978. Determination of carbocysteine from human plasma. J Pharm Sci. 67 (12):1753–1755.
   PubMed Web of Science ®Google Scholar
• MHRA PAR. 2011. Carbocisteine 375 mg capsules, PL 18909/0364; [accessed 2021 Mar 9] https://mhraproducts4853.blob.core.windows.net/docs/dd590fafb364b1eaef4ec5229c7b4f0f96714b1d
   Google Scholar
• Mitchell SC, Steventon GB. 2012. S-Carboxymethyl-L-cysteine. Drug Metab Rev. 44(2):129–147.
   PubMed Web of Science ®Google Scholar
• Nogawa H, Ishibashi Y, Ogawa A, Masuda K, Tsubuki T, Kameda T, Matsuzawa S. 2009. Carbocisteine can scavenge reactive oxygen species in vitro. Respirology. 4:53–59.
   Google Scholar
• Pace E, Di Vincenzo S, Ferraro M, Bruno A, Dino P, Bonsignore MR, Battaglia S, Saibene F, Lanata L, Gjomarkaj M. 2016. Carbocysteine counteracts the effects of cigarette smoke on cell growth and on the SIRT1/FoxO3 axis in bronchial epithelial cells. Exp Gerontol. 81:119–128.
   PubMed Web of Science ®Google Scholar
• Pace E, Di Vincenzo S, Ferraro M, Siena L, Chiappara G, Dino P, Vitulo P, Bertani A, Saibene F, Lanata L, et al. 2017. Effects of carbocysteine and beclomethasone on histone acetylation/deacetylation processes in cigarette smoke exposed bronchial epithelial cells. J Cell Physiol. 232(10):2851–2859.
   PubMed Web of Science ®Google Scholar
• Pace E, Ferraro M, Di Vincenzo S, Cipollina C, Gerbino S, Cigna D, Caputo V, Balsamo R, Lanata L, Gjomarkaj M. 2013a. Comparative cytoprotective effects of carbocysteine and fluticasone propionate in cigarette smoke extract-stimulated bronchial epithelial cells. Cell Stress Chaperones. 18(6):733–743.
   PubMed Web of Science ®Google Scholar
• Pace E, Ferraro M, Siena L, Scafidi V, Gerbino S, Di Vincenzo S, Gallina S, Lanata L, Gjomarkaj M. 2013b. Carbocysteine regulates innate immune responses and senescence processes in cigarette smoke stimulated bronchial epithelial cells. Toxicol Lett. 223(2):198–204.
   PubMed Web of Science ®Google Scholar
• Sanofi-Aventis. 2009. Mucodyne: summary of product characteristics; [accessed 2021 March 5]. http://products.sanofi.co.uk/Mucodyne_SPC.pdf
   Google Scholar
• Sumitomo T, Nakata M, Yamaguchi M, Terao Y, Kawabata S. 2012. S-carboxymethylcysteine inhibits adherence of Streptococcus pneumoniae to human alveolar epithelial cells. J Med Microbiol. 61(Pt 1):101–108.
   PubMed Web of Science ®Google Scholar
• Tatsumi K, Fukuchi Y, Group PS. 2007. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease. J Am Geriatr Soc. 55(11):1884–1886.
   PubMed Web of Science ®Google Scholar
• von Lutz D, Gielsdorf W, Rasper J, Haeger H, Albring M, Eisler G, Niebch G. 1985. Untersuchungen zur Bioverftigbarkeit und Pharmakokinetik zweier Carbocistein-Zubereitungen nach Einfach- und Mehrfachdosierung. Arzneimittel Forschung. 35:163–169.
   PubMedGoogle Scholar
• Wang W, Guan WJ, Huang RQ, Xie Y-Q, Zheng J-P, Zhu S-X, Chen M, Zhong N-S. 2016. Carbocisteine attenuates TNF-α-induced inflammation in human alveolar epithelial cells in vitro through suppressing NF-κB and ERK1/2 MAPK signaling pathways. Acta Pharmacol Sin. 37(5):629–636.
   PubMed Web of Science ®Google Scholar
• Wang W, Zheng JP, Zhu SX, eXie Y-Q, Zheng J-P, Zhu S-X, Chen M, Zhong N-S. 2015. Carbocisteine attenuates hydrogen peroxide-induced inflammatory injury in A549 cells via NF-kappaB and ERK1/2 MAPK pathways. Int Immunopharmacol. 24(2):306–313.
   PubMed Web of Science ®Google Scholar
• Yageta Y, Ishii Y, Morishima Y, Ano S, Ohtsuka S, Matsuyama M, Takeuchi K, Itoh K, Yamamoto M, Hizawa N. 2014. Carbocisteine reduces virus-induced pulmonary inflammation in mice exposed to cigarette smoke. Am J Respir Cell Mol Biol. 50(5):963–973.
   PubMed Web of Science ®Google Scholar
• Yasuda H, Yamaya M, Sasaki T, Inoue D, Nakayama K, Naoki Tomita N, Yoshida M, Sasaki H. 2006. Carbocisteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary disease. J Am Geriatr Soc. 54(2):378–380.
   PubMed Web of Science ®Google Scholar
• Yasuo M, Fujimoto K, Imamura H, Ushiki A, Kanda S, Tsushima K, Kubo H, Yamaya M, Kubo K. 2009. L-Carbocisteine reduces neutrophil elastase-induced mucin production. Respir Physiol Neurobiol. 167(2):214–216.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Nakayama K, Yasuda H, Kubo H, Kuwano K, Arai H, Yamaya M. 2009. Carbocisteine inhibits oxidant-induced apoptosis in cultured human airway epithelial cells. Respirology. 14(7):1027–1034.
   PubMed Web of Science ®Google Scholar
• Zheng J-P, Kang J, Huang S-G, Chen P, Yao W-Z, Yang L, Bai C-X, Wang C-Z, Chen Wang C, Chen B-Y, et al. 2008. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet. 371(9629):2013–2018.
   PubMed Web of Science ®Google Scholar